| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $620K | +71.5% |
| Cost of Revenue | $158K | +80.8% |
| Gross Profit | $463K | +68.5% |
| R&D Expense | $452K | +33.0% |
| SG&A Expense | $1.2M | +8.4% |
| Operating Income | -$1.2M | -3.1% |
| Interest Expense | $263K | -64.4% |
| Net Income | $2.8M | +213.6% |
| EPS (Basic) | $0.01 | +200.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $370K | +4830.5% |
| Accounts Receivable | $78K | — |
| Current Assets | $479K | +5686.7% |
| Total Assets | $1.4M | +2455.8% |
| Current Liabilities | $2.4M | -65.5% |
| Long-term Debt | $27K | — |
| Total Liabilities | $3.9M | -49.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$945K | -311.6% |
| Investing Cash Flow | $441K | — |
| Financing Cash Flow | $866K | +289.1% |
| Stockholders' Equity |
| -$2.5M |
| +66.7% |